Rare entities in head-and-neck cancer: salvage re-irradiation with carbon ions

Bibliographic Details
Title: Rare entities in head-and-neck cancer: salvage re-irradiation with carbon ions
Authors: Thomas Held, Paul Windisch, Sati Akbaba, Kristin Lang, Benjamin Farnia, Jakob Liermann, Denise Bernhardt, Peter Plinkert, Christian Freudlsperger, Stefan Rieken, Klaus Herfarth, Jürgen Debus, Sebastian Adeberg
Source: Radiation Oncology, Vol 14, Iss 1, Pp 1-7 (2019)
Publisher Information: BMC, 2019.
Publication Year: 2019
Collection: LCC:Medical physics. Medical radiology. Nuclear medicine
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Salvage re-irradiation, Head and neck cancer, Carbon ions, Mucoepidermoid carcinoma, Particle therapy, Medical physics. Medical radiology. Nuclear medicine, R895-920, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract Background The objective of this investigation is to evaluate the outcomes and toxicity of carbon-ion re-irradiation (CIR) in patients with rare head and neck cancers (HNC). There is a paucity of data regarding treatment approaches in this patient cohort, which we aim to address in this work. Methods Thirty-two (n = 32) consecutive patients with uncommon HNC treated between 2010 and 2017 were retrospectively analyzed in terms of clinical outcomes, patterns of failure, and toxicity. Results Mucoepidermoid carcinoma (MEC) was the most common histology (22%). Patients received a median cumulative dose equivalent in 2 Gy fractions (EQD2) after CIR of 128.6 Gy (range, 105.8–146.5 Gy). The local and distant control rates 1 year after CIR were 66 and 72%. No serious acute or late toxicity (≥ grade 3) after CIR was observed. Conclusions CIR may represent an effective and safe treatment alternative to palliative systemic therapies in these rare indications.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1748-717X
Relation: http://link.springer.com/article/10.1186/s13014-019-1406-x; https://doaj.org/toc/1748-717X
DOI: 10.1186/s13014-019-1406-x
Access URL: https://doaj.org/article/b5f90db4cb2b4356afc32bf2f2d039e2
Accession Number: edsdoj.b5f90db4cb2b4356afc32bf2f2d039e2
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:1748717X
DOI:10.1186/s13014-019-1406-x
Published in:Radiation Oncology
Language:English